Engineered multivalent self-assembled binder protein against SARS-CoV-2 RBD

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic since December 2019, and with it, a push for innovations in rapid testing and neutralizing antibody treatments in an effort to solve the spread and fatality of the disease. One such solution to both of these pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Britton, Dustin, Punia, Kamia, Mahmoudinobar, Farbod, Tada, Takuya, Jiang, Xunqing, Renfrew, P. Douglas, Bonneau, Richard, Landau, Nathaniel R., Kong, Xiang-Peng, Montclare, Jin Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396458/
https://www.ncbi.nlm.nih.gov/pubmed/36034180
http://dx.doi.org/10.1016/j.bej.2022.108596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396458/
https://www.ncbi.nlm.nih.gov/pubmed/36034180
http://dx.doi.org/10.1016/j.bej.2022.108596

Ejemplares similares